(Total Views: 363)
Posted On: 09/23/2019 3:55:45 PM
Post# of 101
$RIGL News Article - Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia https://marketwirenews.com/news-releases/rige...71904.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
